Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene therapy insertional mutagenesis insights.

× No keyword cloud information.

68 in total

1. Cationic, helical polypeptide-based gene delivery for IMR-90 fibroblasts and human embryonic stem cells.

Authors: Jonathan Yen; Yanfeng Zhang; Nathan P Gabrielson; Lichen Yin; Linna Guan; Isthier Chaudhury; Hua Lu; Fei Wang; Jianjun Cheng
Journal: Biomater Sci Date: 2013-07 Impact factor: 6.843

2. Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors: Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal: J Virol Date: 2006-10 Impact factor: 5.103

Review 3. Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors: Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal: Blood Date: 2005-11-03 Impact factor: 22.113

Review 4. Gene therapy to create biological pacemakers.

Authors: Gerard J J Boink; Jurgen Seppen; Jacques M T de Bakker; Hanno L Tan
Journal: Med Biol Eng Comput Date: 2006-10-18 Impact factor: 2.602

5. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.

Authors: Yang Du; Sally E Spence; Nancy A Jenkins; Neal G Copeland
Journal: Blood Date: 2005-06-16 Impact factor: 22.113

Review 6. Challenges for gene therapy for muscular dystrophy.

Authors: Jerry R Mendell; K Reed Clark
Journal: Curr Neurol Neurosci Rep Date: 2006-01 Impact factor: 5.081

Review 7. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.

Authors: René Daniel; Johanna A Smith
Journal: Hum Gene Ther Date: 2008-06 Impact factor: 5.695

Review 8. Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors: Andre Larochelle; Cynthia E Dunbar
Journal: Semin Hematol Date: 2013-04 Impact factor: 3.851

9. Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors: Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal: ILAR J Date: 2009

10. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.

Authors: Elizabeth M Kang; Uimook Choi; Narda Theobald; Gilda Linton; Debra A Long Priel; Doug Kuhns; Harry L Malech
Journal: Blood Date: 2009-12-01 Impact factor: 22.113